Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback